Artificial Intelligence (AI) in Healthcare

Artificial Intelligence (AI) in Healthcare

Global Artificial Intelligence (AI) in Healthcare Market to Reach US$346.5 Billion by 2030

The global market for Artificial Intelligence (AI) in Healthcare estimated at US$40.5 Billion in the year 2023, is expected to reach US$346.5 Billion by 2030, growing at a CAGR of 35.9% over the analysis period 2023-2030. Software Component, one of the segments analyzed in the report, is expected to record a 37.1% CAGR and reach US$177.2 Billion by the end of the analysis period. Growth in the Hardware Component segment is estimated at 35.4% CAGR over the analysis period.

The U.S. Market is Estimated at US$12.0 Billion While China is Forecast to Grow at 34.2% CAGR

The Artificial Intelligence (AI) in Healthcare market in the U.S. is estimated at US$12.0 Billion in the year 2023. China, the world`s second largest economy, is forecast to reach a projected market size of US$49.8 Billion by the year 2030 trailing a CAGR of 34.2% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 32.1% and 30.2% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 24.7% CAGR.

Global Artificial Intelligence (AI) in Healthcare Market - Key Trends and Drivers Summarized

How Is AI Enhancing Diagnostic Accuracy and Patient Outcomes?

Artificial Intelligence (AI) is transforming diagnostics in healthcare, enabling faster, more accurate assessments that significantly impact patient outcomes. Traditionally, diagnoses relied heavily on a clinician’s expertise and experience, but AI now augments this process by rapidly analyzing medical data and imaging with a level of precision that reduces the likelihood of human error. Machine learning algorithms in radiology, for example, can detect early signs of diseases like cancer, pneumonia, and cardiovascular disorders by scanning imaging data in real time, often identifying issues before symptoms manifest. Companies like Zebra Medical Vision and Aidoc are employing deep learning to interpret CT scans, MRIs, and X-rays with remarkable accuracy, assisting radiologists in making informed decisions quickly. Furthermore, AI models predict patient risks and track disease progression by analyzing electronic health records (EHRs), laboratory results, and genetic information, providing doctors with actionable insights. By enabling faster diagnoses and more personalized treatment plans, AI-driven diagnostics are improving patient outcomes, reducing hospital stays, and paving the way for a more proactive healthcare approach.

Can AI Transform Personalized Treatment and Drug Discovery?

AI’s potential to individualize treatments and expedite drug discovery is redefining how we approach patient care. Precision medicine, a rapidly growing field, leverages AI to customize treatment plans tailored to an individual’s unique genetic makeup, lifestyle, and specific health conditions. By analyzing complex datasets that include genetic information, lifestyle factors, and previous health records, AI algorithms can suggest highly personalized therapies, optimizing treatment efficacy and reducing adverse reactions. IBM’s Watson for Oncology, for instance, uses AI to recommend cancer treatment options based on individual patient data and an extensive library of medical literature, supporting oncologists in making well-informed decisions. In drug discovery, AI accelerates the identification of potential drug candidates, predicting how different molecules might interact and even identifying possible side effects, reducing the time and costs associated with traditional drug development. AI platforms like Atomwise and BenevolentAI use deep learning models to analyze molecular structures, expediting the research process that once took years. By enhancing personalized care and fast-tracking drug discovery, AI is revolutionizing how treatments are developed and delivered, ultimately benefiting patients through more effective and timely medical solutions.

How Is AI Assisting in Operational Efficiency and Resource Management in Healthcare?

AI is driving significant advancements in operational efficiency and resource management within the healthcare sector, addressing longstanding issues like staff shortages, resource allocation, and patient wait times. Hospitals and healthcare providers are utilizing AI-driven predictive analytics to manage scheduling, staff allocation, and patient flow, optimizing these processes to reduce overcrowding and ensure that resources are used efficiently. For example, algorithms can predict peak times in emergency departments or clinics, allowing for better preparation and staffing adjustments, thereby minimizing patient wait times. Additionally, AI in EHR management automates repetitive administrative tasks such as data entry, claims processing, and billing, reducing the administrative burden on healthcare staff and improving overall efficiency. Virtual health assistants and chatbots are further alleviating workload by addressing patient queries, scheduling appointments, and reminding patients of medication, enhancing service quality without overwhelming healthcare personnel. By streamlining operations, AI enables healthcare providers to focus more on direct patient care, increasing efficiency and ensuring resources are deployed where they are most needed.

What Factors Are Driving the Growth of AI in the Healthcare Market?

The growth in the AI in healthcare market is driven by several key factors, as advancements in technology and evolving healthcare needs accelerate AI adoption. Increasing healthcare data volumes, generated from medical imaging, genetic profiles, and wearable health devices, necessitate AI-driven analytics capable of making sense of these massive datasets. Consumer demand for personalized and proactive healthcare services is a primary driver, as patients increasingly expect tailored treatment plans and preventive care options. Technological advancements in natural language processing and computer vision are enhancing AI’s capabilities in interpreting medical data and language-based health information, making AI indispensable for diagnostics, patient monitoring, and personalized medicine. Additionally, the global shift toward value-based care, which emphasizes outcome-driven treatments over volume-based services, aligns closely with AI’s ability to improve diagnostic accuracy, optimize treatment plans, and predict patient outcomes. The rising prevalence of chronic diseases has further increased the need for AI solutions in patient monitoring and management. Government initiatives and private-sector investments in health technology are accelerating research and development in this area, encouraging innovation and expanding AI applications in healthcare. Together, these drivers indicate a transformative period for AI in healthcare, as it responds to both consumer demands and the industry’s shift towards data-centric, efficient, and patient-focused care.

SCOPE OF STUDY:

The report analyzes the Artificial Intelligence (AI) in Healthcare market in terms of US$ Million by the following Application; Component; End-Use; Technology, and Geographic Regions/Countries:

Segments:
Component (Software, Hardware, Services); Technology (Machine Learning, Natural Language Processing, Context-Aware Computing, Computer Vision); Application (Clinical Trials, Robot-Assisted Surgery, Connected Machines, Fraud Detection, Diagnosis, Virtual Assistants, Dosage Error Reduction, Other Applications); End-Use (Hospitals & Healthcare Providers, Patients, Pharmaceuticals & Biotechnology Companies, Healthcare Payers, Other End-Uses)

Geographic Regions/Countries:
World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 222 Featured) -

• Amazon Web Services (Aws)
• Enlitic Inc.
• General Electric Company
• General Vision
• Google
• IBM Corporation
• iCarbonX
• Intel Corporation
• Johnson & Johnson Services
• Koninklijke Philips
• Medtronic
• Micron Technology
• Microsoft Corporation
• Next IT Corp.
• Nvidia Corporation
• Siemens Healthineers (A Strategic Unit Of Siemens Group)
• Welltok Inc.

Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.